Suc-[Glu9, Ala11,15]-Endothelin-1 (8-21)

Code:
4285-v
Name:
Suc-[Glu9, Ala11,15]-Endothelin-1 (8-21)
IRL 1620
Suc-Asp-Glu-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp (Suc: Succinyl)
(M.W. 1820.9) C86H117N17O27
ETB Receptor Selective Agonist
Package Price(Yen) Availability
Vial 0.5 mg 13,000 Ships within
1-3 business days
Bulk Request

main

Purity:
≧99.0% (HPLC)
Storage:
-20 ℃
Production:
Synthetic Product

Solubility: H2O (0.1 mM)

more information

Category:
Biologically Active Peptides

reference

  1. M. Takai, I. Umemura, K. Yamasaki, T. Watakabe, Y. Fujitani, K. Oda, Y. Urade, T. Inui, T. Yamamura, and T. Okada, Biochem. Biophys. Res. Commun., 184, 953 (1992). (Original)
  2. S.S. Shetty, T. Okada, R.L. Webb, D. DelGrande, and R.W. Lappe, Biochem. Biophys. Res. Commun., 191, 459 (1993). (Pharmacol.)
  3. W.G. Haynes, A.P. Davenport, and D.J. Webb, Trends Pharmacol. Sci., 14, 225 (1993). (Meeting Report; 3rd Int, Conf. Endothelin)
  4. A.F. James, Y. Urade, R.L. Webb, H. Karaki, I. Umemura, Y. Fujitani, K. Oda, T. Okada, R.W. Lappe, and M. Takai, Cardiovasc. Drug Rev., 11, 253 (1993). (Review)
  5. M. Yanagisawa and T. Masaki, Trends Pharmacol. Sci., 10, 374 (1989). (Review)
  6. T. Sakurai, M. Yanagisawa, and T. Masaki, Trends Pharmacol. Sci., 13, 103 (1992). (Review)
  7. A.F. James, Y. Urade, R.L. Webb, H. Karaki, I. Umemura, Y. Fujitani, K. Oda, T. Okada, R.W. Lappe, and M. Takai, Cardiovasc. Drug Rev., 11, 253 (1993). (Review)

Documents

PDF SDS:
Japanese / English

Search other product
About Our Product
Technology


Scroll to top